Literature DB >> 18695670

Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice.

Kwangsuk Ko1, Heping Yang, Mazen Noureddin, Ainhoa Iglesia-Ara, Meng Xia, Conrad Wagner, Zigmund Luka, José M Mato, Shelly C Lu.   

Abstract

Endotoxemia participates in the pathogenesis of many liver injuries. Lipopolysaccharide (LPS) was shown to inactivate hepatic methionine adenosyltransferase (MAT), the enzyme responsible for S-adenosylmethionine (SAMe) biosynthesis. SAMe treatment was shown to prevent the LPS-induced increase in tumor necrosis factor-alpha, which may be one of its beneficial effects. SAMe is also an important precursor of glutathione (GSH) and GSH was shown to ameliorate LPS-induced hepatotoxicity. The aims of this work were to examine changes in SAMe and GSH homeostasis during endotoxemia and the effect of SAMe. Mice received SAMe or vehicle pretreatment followed by LPS and were killed up to 18 h afterward. Unexpectedly, we found hepatic SAMe level increased 67% following LPS treatment while S-adenosylhomocysteine level fell by 26%, suggesting an increase in SAMe biosynthesis and/or block in transmethylation. The mRNA and protein levels of MAT1A and MAT2A were increased following LPS. However, despite increased MAT1A expression, MAT activity remained inhibited 18 h after LPS. The major methyltransferase that catabolizes hepatic SAMe is glycine N-methyltransferase, whose expression fell by 65% following LPS. Hepatic GSH level fell more than 50% following LPS, coinciding with a comparable fall in the mRNA and protein levels of glutamate-cysteine ligase (GCL) catalytic (GCLC) and modifier subunits (GCLM). SAMe pretreatment prevented the fall in GCLC and attenuated the fall in GCLM expression and GSH level. SAMe pretreatment prevented the LPS-induced increase in plasma alanine transaminases levels but not the LPS-induced increase in hepatic mRNA levels of proinflammatory cytokines. It further enhanced LPS-induced increase in interleukin-10 mRNA level. Taken together, the hepatic response to LPS is to upregulate MAT expression and inhibit SAMe utilization. GSH is markedly depleted largely due to lower expression of GCL. Interestingly, SAMe treatment prevented the fall in GCL and helped to preserve the GSH store and prevent liver injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695670      PMCID: PMC4467989          DOI: 10.1038/labinvest.2008.69

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  26 in total

1.  S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver.

Authors:  E R García-Trevijano; M U Latasa; M V Carretero; C Berasain; J M Mato; M A Avila
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

2.  Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.

Authors:  S C Lu; L Alvarez; Z Z Huang; L Chen; W An; F J Corrales; M A Avila; G Kanel; J M Mato
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes.

Authors:  P L Majano; C García-Monzón; E R García-Trevijano; F J Corrales; J Cámara; P Ortiz; J M Mato; M A Avila; R Moreno-Otero
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

4.  Enhanced sinusoidal glutathione efflux during endotoxin-induced oxidant stress in vivo.

Authors:  H Jaeschke
Journal:  Am J Physiol       Date:  1992-07

5.  Inducers of gamma-glutamylcysteine synthetase and their effects on glutathione synthetase expression.

Authors:  Z A Huang; H Yang; C Chen; Z Zeng; S C Lu
Journal:  Biochim Biophys Acta       Date:  2000-09-07

6.  Regulation of rat liver S-adenosylmethionine synthetase during septic shock: role of nitric oxide.

Authors:  M A Avila; J Mingorance; M L Martínez-Chantar; M Casado; P Martin-Sanz; L Boscá; J M Mato
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

7.  Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition.

Authors:  C Zhang; L M Walker; J A Hinson; P R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats.

Authors:  S Sun; H Zhang; B Xue; Y Wu; J Wang; Z Yin; L Luo
Journal:  Inflamm Res       Date:  2006-11       Impact factor: 4.575

9.  S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes.

Authors:  Zhenyuan Song; Shirish Barve; Theresa Chen; Wendy Nelson; Silvia Uriarte; Daniell Hill; Craig McClain
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-06       Impact factor: 4.052

Review 10.  Role of S-adenosyl-L-methionine in liver health and injury.

Authors:  José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

View more
  30 in total

1.  Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.

Authors:  Ainara Cano; Xabier Buqué; Maite Martínez-Uña; Igor Aurrekoetxea; Ariane Menor; Juan L García-Rodríguez; Shelly C Lu; M Luz Martínez-Chantar; José M Mato; Begoña Ochoa; Patricia Aspichueta
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

2.  Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.

Authors:  Kwang Suk Ko; Maria Lauda Tomasi; Ainhoa Iglesias-Ara; Barbara A French; Samuel W French; Komal Ramani; Juan José Lozano; Pilsoo Oh; Lina He; Bangyan L Stiles; Tony W H Li; Heping Yang; M Luz Martínez-Chantar; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2010-10-01       Impact factor: 17.425

3.  Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice.

Authors:  Heping Yang; Kwangsuk Ko; Meng Xia; Tony W H Li; Pilsoo Oh; Jiaping Li; Shelly C Lu
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

4.  Down regulation of glutathione and glutamate cysteine ligase in the inflammatory response of macrophages.

Authors:  Hongqiao Zhang; Sarah Jiuqi Zhang; Natalie Lyn; Abigail Florentino; Andrew Li; Kelvin J A Davies; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2020-07-17       Impact factor: 7.376

Review 5.  Glutathione synthesis.

Authors:  Shelly C Lu
Journal:  Biochim Biophys Acta       Date:  2012-09-17

6.  A model for chronic mucosal inflammation in IBD and periodontitis.

Authors:  Helieh S Oz; Theresa Chen; Jeffrey L Ebersole
Journal:  Dig Dis Sci       Date:  2009-11-10       Impact factor: 3.199

7.  S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.

Authors:  Shelly C Lu; Komal Ramani; Xiaopeng Ou; Mark Lin; Victor Yu; Kwangsuk Ko; Ryan Park; Teodoro Bottiglieri; Hidekazu Tsukamoto; Gary Kanel; Samuel W French; José M Mato; Rex Moats; Edward Grant
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

8.  Molecular mechanisms of lipopolysaccharide-mediated inhibition of glutathione synthesis in mice.

Authors:  Maria Lauda Tomasi; Minjung Ryoo; Heping Yang; Ainhoa Iglesias Ara; Kwang Suk Ko; Shelly C Lu
Journal:  Free Radic Biol Med       Date:  2013-12-01       Impact factor: 7.376

Review 9.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

10.  Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications.

Authors:  Heping Yang; Komal Ramani; Meng Xia; Kwang Suk Ko; Tony W H Li; Pilsoo Oh; Jiaping Li; Shelly C Lu
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.